Fran Visco awarded the Presidential Citizens Medal: “We are not going to change what we do or how we do it.”

Oncology has a semantics problem: How do we define “early stage”?

I recently found myself asking a question that I thought had an obvious answer: What is early-stage cancer?

October 09, 2026

Trump administration sends Medicare beneficiaries $90 checks ahead of midterm elections

The Trump administration is sending one-time payments of $90 to Medicare beneficiaries who are enrolled in Part B, according to an executive order signed on Oct. 2.

FDA approves tucatinib + trastuzumab + pertuzumab for maintenance treatment of HER2+ breast cancer

FDA approved Tuksya (tucatinib) in combination with trastuzumab and pertuzumab for the maintenance treatment of adults with unresectable locally advanced or metastatic human epidermal growth factor 2-positive breast cancer following induction treatment. The approval expands the use of Tuksya to frontline, an earlier stage of metastatic disease, offering a new chemotherapy-free maintenance treatment option that may help further delay disease progression.

October 09, 2026

Vol.52 No.37

White House

Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship

Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”

Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?

Nearly two years after FDA issued a final rule requiring radiologists to tell women whether their breasts are “dense” or “not dense” after a mammogram, the notification has become nearly universal.

October 02, 2026

Vol.52 No.36

By Claire Marie Porter

Cancer Policy

Trump targets HHS in $810M appropriations clawback

President Donald Trump has moved to cancel $810 million in government spending that has already been appropriated by Congress.

October 02, 2026

Vol.52 No.36

By Jacquelyn Cobb

Fran Visco awarded the Presidential Citizens Medal: “We are not going to change what we do or how we do it.”

YOU MAY BE INTERESTED IN

Oncology has a semantics problem: How do we define “early stage”?

Trump administration sends Medicare beneficiaries $90 checks ahead of midterm elections

FDA approves tucatinib + trastuzumab + pertuzumab for maintenance treatment of HER2+ breast cancer

Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship

Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?

Trump targets HHS in $810M appropriations clawback

Renew today!

Subscriber content

Never miss an issue!

Login

Fran Visco awarded the Presidential Citizens Medal: “We are not going to change what we do or how we do it.”

YOU MAY BE INTERESTED IN

Oncology has a semantics problem: How do we define “early stage”?

Trump administration sends Medicare beneficiaries $90 checks ahead of midterm elections

FDA approves tucatinib + trastuzumab + pertuzumab for maintenance treatment of HER2+ breast cancer

Michael Caputo appointed to President’s Cancer PanelThe cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship

Two years after FDA’s breast density notification rule, there is still no standard for follow-upSo far, 38 million patients have received a dense breast notification. Now what?

Trump targets HHS in $810M appropriations clawback

Never miss an issue!

Login

Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship

Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?